Benefits of population-level interventions for dementia risk factors: an economic modelling study for England

被引:3
|
作者
Mukadam, Naaheed [1 ,2 ]
Anderson, Robert [3 ]
Walsh, Sebastian [4 ]
Wittenberg, Raphael [3 ]
Knapp, Martin [3 ]
Brayne, Carol [4 ]
Livingston, Gill [1 ,2 ]
机构
[1] UCL, UCL Div Psychiat, London WC1E 6BT, England
[2] Camden & Islington NHS Fdn Trust, London, England
[3] London Sch Econ & Polit Sci, Care Policy & Evaluat Ctr, London, England
[4] Univ Cambridge, Cambridge Publ Hlth, Cambridge, England
来源
LANCET HEALTHY LONGEVITY | 2024年 / 5卷 / 09期
关键词
COST-EFFECTIVENESS; MORTALITY; HEALTH; REDUCE; IMPACT; WALES; TREND;
D O I
10.1016/S2666-7568(24)00117-X
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background Individual-level interventions for dementia risk factors could reduce costs associated with dementia and some are cost-effective. We aimed to estimate the cost-effectiveness of population-level interventions for tackling dementia risk factors. Methods In this economic modelling study, we included recommended population-based interventions from a previously published review article for which there was consistent and robust evidence of effectiveness in tackling a dementia risk factor (tobacco smoking, excess alcohol use, hypertension, obesity, air pollution, and head injury). We only included interventions if they had not been introduced in England or were in place but could be extended. The interventions studied were increases in tobacco pricing, minimum pricing for alcohol, raising alcohol price, salt reduction policies, sugar reduction policies, low emission zones, and compulsory helmet use for cycling by children (aged 5-18 years). We used published intervention effect sizes and relative risks for each risk factor and a Markov model to estimate progression to dementia in populations with and without the intervention, looking at lifetime risk, in the population of England. Findings We estimated that reductions in excess alcohol use through minimum unit pricing would lead to cost-savings of 280 pound million and 4767 quality-adjusted life-years (QALYs) gained over an indefinite succession of age cohorts. Reformulation of food products to reduce salt would lead to cost-savings of 2 pound<middle dot>4 billion and 39 433 QALYs gained and reformulation to reduce sugar would lead to cost-savings of 1 pound<middle dot>046 billion and 17 985 QALYs gained. Reducing dementia risk from air pollution by introducing low emission zones in English cities with a population of 100 000 or more (that do not already impose restrictions) would lead to 260 pound million cost-savings and 5119 QALYs gained. Raising cigarette prices by 10% to reduce dementia risk from smoking would lead to 2277 QALYs gained and cost-savings of 157 pound million. Making bicycle helmets compulsory for children (aged 5-18 years) to reduce dementia risk from head injury would lead to cost-savings of 91 pound million and 1554 QALYs gained. Interpretation Population-level interventions could help tackle life course dementia risk and save costs.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Relative Benefits of Population-Level Interventions Targeting Restraint-Use in Child Car Passengers
    Du, Wei
    Finch, Caroline F.
    Hayen, Andrew
    Bilston, Lynne
    Brown, Julie
    Hatfield, Julie
    PEDIATRICS, 2010, 125 (02) : 304 - 312
  • [22] DEMENTIA PREVENTION AT THE POPULATION LEVEL: MODIFIABLE RISK FACTORS
    Yaffe, Kristine
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (04): : S49 - S49
  • [23] Population-Level Incidence and Risk Factors for Pulmonary Toxicity Associated With Amiodarone
    Jackevicius, Cynthia Anne
    Tom, Albert
    Essebag, Vidal
    Eisenberg, Mark J.
    Rahme, Elham
    Tu, Jack Ven
    Humphries, Karin
    Behlouli, Hassan
    Pilote, Louise
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 108 (05): : 705 - 710
  • [24] Pulmonary Toxicity Associated With Amiodarone: Population-Level Incidence and Risk Factors
    Jackevicius, Cynthia
    Tom, Albert
    Essebag, Vidal
    Eisenberg, Mark
    Rahme, Elham
    Tu, Jack
    Humphries, Karin
    Behlouli, Hassan
    Richard, Hugues
    Pilote, Louise
    CIRCULATION, 2009, 120 (18) : S521 - S521
  • [25] A population-level study of place of death and associated factors in Sweden
    Hakanson, Cecilia
    Ohlen, Joakim
    Morin, Lucas
    Cohen, Joachim
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2015, 43 (07) : 744 - 751
  • [26] Age Group Differences in the Awareness of Lifestyle Factors Impacting Cardiovascular Risk: A Population-Level Study
    Okobi, Okelue E.
    Adeyemi, Ayomide H.
    Nwimo, Patience N.
    Nwachukwu, Onyinyechukwu B.
    Eziyi, Ure K.
    Okolie, Cynthia O.
    Orisakwe, Georgenia
    Olasoju, Faith A.
    Omoike, Omouyi J.
    Ihekire, Linda Nkechinyere
    Afrifa-Yamoah, Jeffrey
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [27] Optimum population-level use of artemisinin combination therapies: a modelling study
    Nguyen, Tran Dang
    Olliaro, Piero
    Dondorp, Arjen M.
    Baird, J. Kevin
    Lam, Ha Minh
    Farrar, Jeremy
    Thwaites, Guy E.
    White, Nicholas J.
    Boni, Maciej F.
    LANCET GLOBAL HEALTH, 2015, 3 (12): : E758 - E766
  • [28] Population-level pharmacogenomics for precision drug development in dementia
    Cacabelos, Ramon
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2018, 3 (03): : 163 - 188
  • [29] Rising incidence of Pneumocystis pneumonia: A population-level descriptive ecological study in England
    Pates, Katharine
    Periselneris, Jimstan
    Russell, Mark D.
    Mehra, Varun
    Schelenz, Silke
    Galloway, James B.
    JOURNAL OF INFECTION, 2023, 86 (04) : 385 - 390
  • [30] No evidence for population-level benefits of polyandry in sharks and rays
    Gayford, Joel H.
    Flores-Flores, Estefania M.
    PLOS ONE, 2024, 19 (09):